연구물
110건 검색
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
Lee, Choong-kunYoo, ChanghoonHong, Jung YongPark, Se JunKim, Jin Won오상보외 24명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3 beta-dependent Snail degradation
Targeting tumor-intrinsic PD-L1 suppresses the progression and aggressiveness of head and neck cancer by inhibiting GSK3β-dependent Snail degradation
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Abou-Alfa, Ghassan K.Galle, Peter R.Chao, YeeErinjeri, Joseph허정외 9명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Association between immunotherapy biomarkers and glucose metabolism from F-18 FDG PET
- 연구출판물 · 학술지 논문JCR Q2Scopus Q3Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study
- 연구출판물 · 학술지 논문JCR Q3Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells
- 연구출판물 · 학술지 논문JCR Q4Scopus Q4Counteracting the activation of pAkt by inhibition of MEK/Erk inhibition reduces actin disruption-mediated apoptosis in PTEN-null PC3M prostate cancer cell lines
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab plus bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma.
Kim, KevinSaeed, AnwaarSohal, DavendraEdeline, Julien허정외 3명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
- 연구출판물 · 리뷰논문JCR Q1Scopus Q1EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.
Lencioni, RiccardoKudo, MasatoshiErinjeri, JosephQin, ShukuiRen, Zhenggang허정외 14명



로그인
홈
Researcher Page
ORCID
ISNI